DK1200092T3 - Beta-carbolin-lægemiddelprodukter - Google Patents
Beta-carbolin-lægemiddelprodukterInfo
- Publication number
- DK1200092T3 DK1200092T3 DK00952371T DK00952371T DK1200092T3 DK 1200092 T3 DK1200092 T3 DK 1200092T3 DK 00952371 T DK00952371 T DK 00952371T DK 00952371 T DK00952371 T DK 00952371T DK 1200092 T3 DK1200092 T3 DK 1200092T3
- Authority
- DK
- Denmark
- Prior art keywords
- carboline
- beta
- drug products
- drug
- products
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Gynecology & Obstetrics (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Physical Or Chemical Processes And Apparatus (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14704899P | 1999-08-03 | 1999-08-03 | |
| PCT/US2000/020981 WO2001008688A2 (en) | 1999-08-03 | 2000-08-01 | Beta-carboline drug products |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1200092T3 true DK1200092T3 (da) | 2004-08-16 |
Family
ID=22520112
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK00952371T DK1200092T3 (da) | 1999-08-03 | 2000-08-01 | Beta-carbolin-lægemiddelprodukter |
Country Status (33)
| Country | Link |
|---|---|
| EP (1) | EP1200092B1 (da) |
| JP (1) | JP4456788B2 (da) |
| KR (1) | KR20020063842A (da) |
| CN (2) | CN1377270A (da) |
| AR (1) | AR033953A1 (da) |
| AT (1) | ATE264680T1 (da) |
| AU (1) | AU773666B2 (da) |
| BR (1) | BR0012901A (da) |
| CA (1) | CA2380087C (da) |
| CO (1) | CO5200849A1 (da) |
| CZ (1) | CZ300151B6 (da) |
| DE (1) | DE60010089T2 (da) |
| DK (1) | DK1200092T3 (da) |
| DZ (1) | DZ3180A1 (da) |
| EA (1) | EA004302B9 (da) |
| ES (1) | ES2220506T3 (da) |
| HK (1) | HK1044278B (da) |
| HR (1) | HRP20020091B1 (da) |
| HU (1) | HU229443B1 (da) |
| IL (1) | IL147642A0 (da) |
| MX (1) | MXPA02001197A (da) |
| MY (1) | MY125428A (da) |
| NO (1) | NO321602B1 (da) |
| NZ (1) | NZ516613A (da) |
| PE (1) | PE20010480A1 (da) |
| PL (1) | PL199469B1 (da) |
| PT (1) | PT1200092E (da) |
| SK (1) | SK286365B6 (da) |
| SV (1) | SV2002000137A (da) |
| TW (1) | TWI235658B (da) |
| UA (1) | UA71629C2 (da) |
| WO (1) | WO2001008688A2 (da) |
| ZA (1) | ZA200200825B (da) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SK287869B6 (sk) * | 1999-08-03 | 2012-02-03 | Icos Corporation | Beta-carboline pharmaceutical compositions |
| EP2216329A1 (en) * | 2004-10-28 | 2010-08-11 | Dr. Reddy's Laboratories Ltd. | Processes for the preparation of tadalafi |
| DE602006004694D1 (de) * | 2006-01-05 | 2009-02-26 | Teva Pharma | Feuchtgranulierungsmethode zur Herstellung pharmazeutischer Aripiprazolzusammensetzungen |
| DE102007028869A1 (de) | 2007-06-22 | 2008-12-24 | Ratiopharm Gmbh | Verfahren zur Herstellung eines Arzneimittels enthaltend Tadalafil |
| MD4009C2 (ro) * | 2008-07-15 | 2010-08-31 | Институт Химии Академии Наук Молдовы | Utilizarea 1-metil-4-(N-metilaminobutil-4)-β-carbolinei în calitate de remediu antituberculos |
| DE102009033396A1 (de) | 2009-07-16 | 2011-01-20 | Ratiopharm Gmbh | Wässrige Lösung und gelatinierte Zusammensetzung umfassend einen Phosphodiesterase-5-Inhibitor sowie diesbezügliche Verfahren und Verwendung |
| DE102009035211A1 (de) | 2009-07-29 | 2011-02-17 | Ratiopharm Gmbh | Copräzipitate umfassend einen Phosphodiesterase-5-Inhibitor (PDE-5-Inhibitor) und einen pharmazeutisch verträglichen Trägerstoff, ihre Herstellung und Verwendung |
| WO2012085927A2 (en) * | 2010-12-02 | 2012-06-28 | Mylan Laboratories, Limited | Tadalafil compositions |
| WO2012095151A1 (en) | 2010-12-23 | 2012-07-19 | Zaklady Farmaceutyczne Polpharma Sa | Solid pharmaceutical dosage forms comprising tadalafil and methods of preparation thereof |
| RU2013141446A (ru) | 2011-02-10 | 2015-03-20 | Синтон Бв | Фармацевтическая композиция, содержащая тадалафил и циклодекстрин |
| WO2012107092A1 (en) | 2011-02-10 | 2012-08-16 | Synthon Bv | Pharmaceutical composition comprising tadalafil and a cyclodextrin |
| WO2012107090A1 (en) | 2011-02-10 | 2012-08-16 | Synthon Bv | Granulated composition comprising tadalafil and a disintegrant |
| JP5930686B2 (ja) * | 2011-12-07 | 2016-06-08 | 株式会社トクヤマ | 溶解性および安定性の向上した難溶性医薬品原体及びその製造方法 |
| US9871201B2 (en) | 2012-03-15 | 2018-01-16 | Merck Patent Gmbh | Electronic devices |
| WO2014003678A1 (en) * | 2012-06-28 | 2014-01-03 | Xspray Microparticles Ab | Pharmaceutical compositions comprising ambrisentan and solid dispersion particles containing tadalafil |
| WO2014003677A1 (en) * | 2012-06-28 | 2014-01-03 | Xspray Microparticles Ab | Pharmaceutical compositions comprising solid dispersion particles containing tadalafil |
| CN105310984A (zh) * | 2014-06-10 | 2016-02-10 | 合肥贝霓医药科技有限公司 | 一种pde5抑制剂的超微粉体及其制备方法 |
| EP3111929B1 (en) * | 2014-06-24 | 2018-08-29 | Wooshin Labottach Co., Ltd. | Oral disintegrating film formulation containing tadalafil and preparation method therefor |
| SI3466951T1 (sl) | 2014-07-23 | 2022-05-31 | Krka, D.D., Novo Mesto | Proces za pripravo zaviralca CGMP-fosfodiesteraze in oralne farmacevtske formulacije, ki obsega koprecipitate tadalafila |
| JP2016106139A (ja) * | 2016-03-07 | 2016-06-16 | 株式会社トクヤマ | 溶解性および安定性の向上した難溶性医薬品原体及びその製造方法 |
| US11464778B2 (en) * | 2017-12-26 | 2022-10-11 | Liqmeds Worldwide Limited | Liquid oral formulations for sildenafil |
| EP3510997B1 (en) | 2018-01-10 | 2020-08-05 | Gap S.A. | Soft gelatin capsules comprising a suspension of tadalafil |
| CN110638770B (zh) * | 2019-10-25 | 2022-04-05 | 株洲千金药业股份有限公司 | 他达拉非片剂的制备方法及以该方法制得的片剂 |
| WO2023227185A1 (en) | 2022-05-27 | 2023-11-30 | Rontis Hellas S.A. | Improved pharmaceutical composition containing tadalafil and nanomilling process for the preparation thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5618845A (en) * | 1994-10-06 | 1997-04-08 | Cephalon, Inc. | Acetamide derivative having defined particle size |
| GB9511220D0 (en) * | 1995-06-02 | 1995-07-26 | Glaxo Group Ltd | Solid dispersions |
-
2000
- 2000-01-08 UA UA2002010773A patent/UA71629C2/uk unknown
- 2000-08-01 NZ NZ516613A patent/NZ516613A/en not_active IP Right Cessation
- 2000-08-01 PL PL353268A patent/PL199469B1/pl unknown
- 2000-08-01 AT AT00952371T patent/ATE264680T1/de active
- 2000-08-01 SK SK172-2002A patent/SK286365B6/sk not_active IP Right Cessation
- 2000-08-01 BR BR0012901-1A patent/BR0012901A/pt not_active Application Discontinuation
- 2000-08-01 IL IL14764200A patent/IL147642A0/xx active IP Right Grant
- 2000-08-01 CN CN00813777A patent/CN1377270A/zh active Pending
- 2000-08-01 PT PT00952371T patent/PT1200092E/pt unknown
- 2000-08-01 DK DK00952371T patent/DK1200092T3/da active
- 2000-08-01 AU AU65084/00A patent/AU773666B2/en not_active Expired
- 2000-08-01 CZ CZ20020387A patent/CZ300151B6/cs not_active IP Right Cessation
- 2000-08-01 WO PCT/US2000/020981 patent/WO2001008688A2/en active Search and Examination
- 2000-08-01 CA CA002380087A patent/CA2380087C/en not_active Expired - Lifetime
- 2000-08-01 EP EP00952371A patent/EP1200092B1/en not_active Expired - Lifetime
- 2000-08-01 MX MXPA02001197A patent/MXPA02001197A/es active IP Right Grant
- 2000-08-01 CN CNA2007101408018A patent/CN101134019A/zh active Pending
- 2000-08-01 HU HU0202781A patent/HU229443B1/hu unknown
- 2000-08-01 KR KR1020027001407A patent/KR20020063842A/ko active Search and Examination
- 2000-08-01 DZ DZ003180A patent/DZ3180A1/xx active
- 2000-08-01 ES ES00952371T patent/ES2220506T3/es not_active Expired - Lifetime
- 2000-08-01 JP JP2001513418A patent/JP4456788B2/ja not_active Expired - Lifetime
- 2000-08-01 DE DE60010089T patent/DE60010089T2/de not_active Expired - Lifetime
- 2000-08-01 EA EA200200119A patent/EA004302B9/ru not_active IP Right Cessation
- 2000-08-02 MY MYPI20003524 patent/MY125428A/en unknown
- 2000-08-02 CO CO00058156A patent/CO5200849A1/es not_active Application Discontinuation
- 2000-08-03 TW TW089115586A patent/TWI235658B/zh not_active IP Right Cessation
- 2000-08-03 PE PE2000000773A patent/PE20010480A1/es not_active IP Right Cessation
- 2000-08-03 AR ARP000104015A patent/AR033953A1/es not_active Application Discontinuation
- 2000-08-07 SV SV2000000137A patent/SV2002000137A/es unknown
-
2002
- 2002-01-29 HR HR20020091A patent/HRP20020091B1/xx not_active IP Right Cessation
- 2002-01-30 ZA ZA200200825A patent/ZA200200825B/en unknown
- 2002-02-01 NO NO20020531A patent/NO321602B1/no unknown
- 2002-06-19 HK HK02104540.5A patent/HK1044278B/zh not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1200092T3 (da) | Beta-carbolin-lægemiddelprodukter | |
| NO20022970L (no) | Hydrogel-drevet medikamentdoseringsform | |
| DE60016271D1 (de) | Medikamentenzuführvorrichtung | |
| NO20015175L (no) | Farmasöytisk sammensetning | |
| ATE411068T1 (de) | Medikamentspender | |
| NO20020464D0 (no) | Flerkomponent-farmasöytisk doseringsform | |
| FI4823U1 (fi) | Muunnetulla tavalla vapauttava lääkeformulaatio | |
| DK1128831T3 (da) | Farmaceutisk moxifloxacinpræparat | |
| NO20020086L (no) | Smaksmaskerte farmasöytiske flytende formuleringer | |
| NO20015670D0 (no) | Forbedrede farmasöytiske formuleringer | |
| PT1173434E (pt) | Novo produto farmaceutico | |
| NO20022606D0 (no) | Farmasöytiske kombinasjoner | |
| DK1275397T3 (da) | Lægemiddel til lokal anvendelse | |
| NO20014926D0 (no) | Farmasöytiske forbindelser | |
| FR2802423B1 (fr) | Compositions pharmaceutiques | |
| FI4488U1 (fi) | Farmaseuttinen koostumus | |
| EE200100697A (et) | Farmatseutiline kompleks | |
| AR025867A1 (es) | Formulacion portasdora farmaceutica | |
| NO20021036L (no) | Farmasöytisk preparat | |
| SI1200092T1 (en) | Beta-carboline drug products | |
| ATA173599A (de) | Pharmazeutisches produkt | |
| FIU990361U0 (fi) | Hammaslankatuote | |
| FIU990118U0 (fi) | Hammaslankatuote | |
| DK1183061T3 (da) | Lægemiddelafgivelsessystem | |
| UA3648S (uk) | Пляшка для лікеро-горілчаних виробів |